Skip to main content
. 2024 Sep 5;14(9):e081398. doi: 10.1136/bmjopen-2023-081398

Table 3. Medios AI-AMD diagnosis versus ophthalmologist diagnosis.

AMD diagnosis Medios AI-AMD for target device
Validation set Test set
Non-referable AMD Referable AMD Non-referable AMD Referable AMD
Ophthalmologist grading*
 No AMD 104 12 105 10
 Early AMD 20 6 18 7
Non-referable 12 5 10 8
Intermediate
 AMD 4 32 5 35
 Advanced AMD 5 31 32
Referable * 6 0 6
Diagnostic accuracy, %
 Recall No AMD 89.66(95% CI: 82.6 to 94.5) 91.30(95% CI: 84.6 to 95.8)
 Recall Early AMD 76.92(95% CI: 56.4 to 91.0) 72.00(95% CI: 50.6 to 87.9)
 Recall Intermediate AMD 88.89(95% CI: 73.9 to 96.9) 87.50(95% CI: 73.2 to 95.8)
 Recall Advanced AMD 86.11(95% CI: 70.5 to 95.3) 94.12(95% CI: 80.3 to 99.3)
*

Ground Ttruth.

No consensus, but 2two out 3three ophthalmologists graded non-referable.

No consensus, but 2two out 3three ophthalmologists graded referable.

AIartificial intelligenceAMDage-related macular degeneration